Entry of Herpes Simplex Virus Type 1 (HSV-1) into the Distal Axons of Trigeminal Neurons Favors the Onset of Nonproductive, Silent Infection by Hafezi, Wali et al.
Entry of Herpes Simplex Virus Type 1 (HSV-1) into the
Distal Axons of Trigeminal Neurons Favors the Onset of
Nonproductive, Silent Infection
Wali Hafezi
1,2., Eva U. Lorentzen
1., Bodo R. Eing
1¤, Marcus Mu ¨ller




5, Joachim E. Ku ¨hn
1,2*
1University Hospital Mu ¨nster, Institute of Medical Microbiology - Clinical Virology, Mu ¨nster, Germany, 2Interdisciplinary Center of Clinical Research (IZKF), Mu ¨nster,
Germany, 3University Hospital Bonn, Department of Neurology, Bonn, Germany, 4University of Sydney, Sydney Medical School, Department of Pathology, Bosch Institute
for Medical Research, New South Wales, Australia, 5Friedrich-Loeffler-Institut, Institute of Molecular Biology, Greifswald-Insel Riems, Germany
Abstract
Following productive, lytic infection in epithelia, herpes simplex virus type 1 (HSV-1) establishes a lifelong latent infection in
sensory neurons that is interrupted by episodes of reactivation. In order to better understand what triggers this lytic/latent
decision in neurons, we set up an organotypic model based on chicken embryonic trigeminal ganglia explants (TGEs) in a
double chamber system. Adding HSV-1 to the ganglion compartment (GC) resulted in a productive infection in the explants.
By contrast, selective application of the virus to distal axons led to a largely nonproductive infection that was characterized
by the poor expression of lytic genes and the presence of high levels of the 2.0-kb major latency-associated transcript (LAT)
RNA. Treatment of the explants with the immediate-early (IE) gene transcriptional inducer hexamethylene bisacetamide,
and simultaneous co-infection of the GC with HSV-1, herpes simplex virus type 2 (HSV-2) or pseudorabies virus (PrV) helper
virus significantly enhanced the ability of HSV-1 to productively infect sensory neurons upon axonal entry. Helper-virus-
induced transactivation of HSV-1 IE gene expression in axonally-infected TGEs in the absence of de novo protein synthesis
was dependent on the presence of functional tegument protein VP16 in HSV-1 helper virus particles. After the
establishment of a LAT-positive silent infection in TGEs, HSV-1 was refractory to transactivation by superinfection of the GC
with HSV-1 but not with HSV-2 and PrV helper virus. In conclusion, the site of entry appears to be a critical determinant in
the lytic/latent decision in sensory neurons. HSV-1 entry into distal axons results in an insufficient transactivation of IE gene
expression and favors the establishment of a nonproductive, silent infection in trigeminal neurons.
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Introduction
Herpes simplex virus type 1 (HSV-1) and 2 (HSV-2) are
prototypic members of the genus Simplexvirus within the herpes-
virus subfamily Alphaherpesvirinae. In vitro, HSVs are pantropic,
causing lytic infections in various tissues and cell types of a broad
range of host species [1]. In vivo, humans are the only natural hosts
of HSVs, and infection is almost exclusively limited to the
epithelial cells and neurons of the peripheral nervous system
(PNS). The portal of entry in HSV-1 infections is the oronasal
mucosa, where the virus spreads rapidly with productive, lytic
infection of epithelial cells [2]. HSV-1 reaches the PNS by entry
into free nerve endings that are in contact with the infected
epithelium, and by retrograde axonal transport [3]. Beyond the
neonatal period, replication of HSV-1 within the PNS is tightly
controlled, and further ascending spread into the central nervous
system is prevented in the immunocompetent host. As a result,
HSV-1 establishes latency in surviving neurons, converting them
into a lifelong reservoir of recurrent infection, which occurs in
response to diverse stimuli causing neuronal stress [4]. The ability
to switch from rapidly progressing, lytic spread in epithelia to a
nonproductive, latent infection in sensory neurons is fundamental
to the life cycle of HSVs and other related alphaherpesviruses.
Although crucial for our understanding of the pathogenesis of
alphaherpesvirus infection, the events that ultimately trigger the
establishment of latent infection in sensory neurons are not fully
understood. The latency-associated transcript (LAT) is abundantly
expressed in infected neurons, and has been shown to promote the
establishment and maintenance of latency, in part because of the
anti-apoptosis functions of LAT and the ability of micro-RNAs
and other small non-coding RNAs encoded by LAT to interfere
with productive infection [4].
PLoS Pathogens | www.plospathogens.org 1 May 2012 | Volume 8 | Issue 5 | e1002679The viral proteins ICP0 and VP16 have both been implicated in
the lytic/latent decision in the infected neuron [5]. The HSV-1
immediate-early (IE) regulatory protein ICP0 is a RING finger E3
ubiquitin ligase that acts as a promiscuous activator of gene
expression and is critical for the efficient initiation of productive
infection, the prevention of cellular silencing of viral transcription,
and reactivation from latency [6]. Central to the function of HSV-
1 ICP0 and functional homologues in other alphaherpesviruses is
the ability of ICP0 to degrade PML nuclear bodies (also known as
nuclear domain 10, ND10) and to disrupt the ND10-dependent
antiviral interferon response and other cellular functions linked to
ND10 [7,8]. HSV-1 ICP0 has been found to functionally interact
with class II histone deacetylases (HDAC), to dissociate HDAC
from the lysine-specific demethylase 1/REST/CoREST repressor
complex, and to promote histone removal and acetylation, thus
preventing the formation of inactive chromatin on the HSV-1
genome [9–11]. Posttranslational histone modifications have been
implied in HSV gene expression during lytic and latent infection,
and the establishment, maintenance, and reactivation from latency
[12–16].
HSV-1 VP16 (also designated pUL48 or alpha-transinducing
factor, aTIF) is a structural component of the tegument layer.
Upon fusion with the cytoplasmic membrane of monolayer cells,
HSV-1 particles deliver 500–1,000 molecules of VP16 into the
cytoplasm, which are transported to the nucleus independently of
capsids [17].
Although purified in vitro de-enveloped HSV-1 particles
containing a VP16-EGFP fusion protein were reported to move
in a retrograde direction along microtubules when injected into
squid giant axons [18], several studies of HSV-1 and other
alphaherpesviruses have demonstrated that VP16 dissociates from
viral particles upon entry into the host cell and that capsids are
transported to the nucleus independently of VP16 [19–21]. Live-
cell imaging experiments examining the retrograde axonal
transport of pseudorabies virus (PrV) and HSV-1 in neurons of
human, mouse and avian origin have shown that VP16 and other
proteins of the outer tegument layer are predominantly lost from
the nucleocapsid prior to the onset of retrograde axonal transport,
and do not move with the capsid to the nucleus [22].
However, it was also noted that to some extent VP16 appears to
be axonally transported in retrograde direction independent of
capsids.
In lytic infection, VP16 forms a tripartite complex with the
cellular proteins HCF-1 and Oct-1, which binds to the
TAATGARAT elements present in HSV IE promoters and acts
as a potent transcriptional activator of IE gene expression [23–26].
The transcriptional activation domain of HSV-1 VP16 (VP16AD)
interacts with a large number of cellular factors that are involved
in gene activation [27]. Although not essential for IE gene
expression, coactivators recruited by the HSV-1 VP16AD
contribute to relatively low levels of histones on the viral genome
during lytic infection [28–31]. VP16 is essential for stress-induced
HSV-1 reactivation in vitro [32]. Exit from latency following heat
shock in the mouse ocular model has been reported to depend on
the de novo activation of the VP16 promoter and synthesis of VP16
in infected neurons [33]. In stressed neurons, HCF-1 has been
shown to relocalize from the cytoplasm to the nucleus and to be
recruited to HSV-1 IE promoters [34]. The regulated relocaliza-
tion of de novo synthesized VP16 and HCF-1 from the cytoplasm to
the nucleus of stressed neurons appears to be a critical step in the
initiation of lytic gene expression during reactivation from latency
[35]. In addition to its regulatory function in IE gene expression,
VP16 and homologous alphaherpesvirus proteins of the outer
tegument layer mediate essential functions related to viral egress
[36].
At present, animal models allow only a pinpoint, snapshot-like
observation of the critical early phase of viral arrival in the PNS
and onset of replication. Furthermore, there is enormous variation
in the outcome of HSV-1 infection of the nervous system in
laboratory animals. In mice, the course of infection depends on
various factors, including the viral strain, infectious dose, route of
infection, mouse strain and age, and prior immunization history of
the animal [37]. As an alternative to animal models, classical or
modified Campenot chambers and microfluidic devices have been
used to study the directional spread of alphaherpesviruses between
epithelial cells and neurons in compartmentalized organotypic
culture systems [38–42]. The directional spread of HSV-1
between epithelia and the PNS has been analyzed in our
laboratory by establishing compartment cultures based on chick
embryonic corneal epithelial cells and trigeminal ganglion (TG)
explants (TGEs) [43].
The aim of the present study was to identify factors triggering
either productive or silent infection of sensory neurons by
mimicking the critical early phase of primary PNS infection in
organotypic cultures ex vivo. Interestingly, remarkable differences
in the ability of HSV-1 to initiate productive infection in sensory
neurons were observed depending on the site used to infect the
explants. In accordance with earlier reports [22,43,44], productive
infection was easily induced in embryonic chicken neurons by
directly adding the viral inoculum to the explant cultures. In
contrast, upon entry into distal axons, incoming HSV-1 genomes
were largely destined to a quiescent, latency-like infection,
characterized by the expression of high levels of the latency-
associated transcript (LAT). HSV-1 remained responsive to the IE
gene transcriptional inducer hexamethylene bisacetamide
(HMBA), and to transcriptional transactivation by simultaneous
co-infection of the ganglion compartment (GC) with helper virus.
Efficient transactivation was dependent on the presence of
functional VP16 in HSV-1 helper virus particles. To our
Author Summary
Upon primary infection of the oronasal mucosa, herpes
simplex virus type 1 (HSV-1) rapidly reaches the ganglia of
the peripheral nervous system via axonal transport and
establishes lifelong latency in surviving neurons. Central to
the establishment of latency is the ability of HSV-1 to
reliably switch from productive, lytic spread in epithelia to
nonproductive, latent infection in sensory neurons. It is not
fully understood what specifically disposes incoming
particles of a highly cytopathogenic, fast-replicating
alphaherpesvirus to nonproductive, latent infection in
sensory neurons. The present study shows that selective
entry of HSV-1 into the distal axons of trigeminal neurons
strongly favors the establishment of a nonproductive,
latent infection, whereas nonselective infection of neurons
still enables HSV-1 to induce lytic gene expression. Our
data support a model of latency establishment in which
the site of entry is an important determinant of the lytic/
latent decision in the infected neuron. Productive infection
of the neuron ensues if particles enter the soma of the
neuron directly. In contrast, previous retrograde axonal
transport of incoming viral particles creates a distinct
scenario that abrogates VP16-dependent transactivation of
immediate-early gene expression and precludes the
expression of lytic genes to an extent sufficient to prevent
the initiation of massive productive infection of trigeminal
neurons.
Silent HSV Infection of Neurons upon Axonal Entry
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that axonal infection and preceding retrograde axonal transport of
subviral particles strongly diminishes the ability of HSV-1 to
initiate a productive infection of neurons, most likely via a failure
of VP16-induced expression of lytic genes.
Results
Experimental setup of the organ model explant cultures
In the present study we analyzed the course of a synchronous
HSV-1 infection of TGE cultures resulting from the application of
a defined viral inoculum to either free nerve endings or directly to
the explants. TGEs were derived from day-15 chicken embryos, as
described previously [43]. Selective HSV-1 infection of distal
axons was achieved with the aid of a Campenot-like compartment
chamber [38], in which the inner compartment containing the
TGE (i.e., the GC) was separated by a leak-proof diffusion barrier
from the outer compartment containing the distal axons [the
axonal compartment (AC)] (Figure 1A). Infection of the respective
compartment was performed after 5–6 days of in vitro cultivation.
Staining of the AC with the retrograde neuronal tracer DiI showed
that at this time point approximately 200 neurites/TGE had
crossed the diffusion barrier and reached the AC. Neurites within
the AC were essentially free of accompanying glial cells. By 48 h
after applying DiI to the AC, approximately 100 neurons/TGE
could be visualized in intact cultures. DiI-positive neurons
exhibited a characteristic morphology with a large, rounded
soma, and were mostly localized at the margin of the explant.
Many neurons contained prominently stained neurites (Figure 1B–
D).
Direct infection of the GC with HSV-1 17 CMV-IEproEGFP
expressing EGFP under control of the CMV IE-promoter, and
monitoring of the reporter protein expression in intact cultures by
fluorescence microscopy demonstrated that embryonic chicken
TGEs are susceptible to productive HSV-1 infection under the
culture conditions used. By 24 h after infection [hours post
infection (hpi)] of the GC with 1610
6 plaque-forming units (pfu) of
HSV-1 17 CMV-IEproEGFP, the vast majority of cells directly
accessible to the virus inoculum strongly expressed EGFP.
Costaining of the AC with DiI allowed the identification of
EGFP-positive neurons with neurites reaching the AC (Figure 2A).
Approximately 30% of DiI-positive neurons (53 out of 163
neurons) were found to be EGFP-positive at 24 hpi (Figure 2C).
According to their morphology, most of the remaining DiI-
negative, EGFP-positive cells appeared to be macroglial cells, most
likely Schwann cells.
Selective infection of the AC
We next studied the retrograde spread of HSV-1 in intact TGEs
by the addition of HSV-1 17 CMV-IEproEGFP to the AC and
daily monitoring of cultures by fluorescence microscopy.
In preliminary experiments, various infectious doses and
protocols for infection of the AC were evaluated. Except where
indicated otherwise, an inoculum of 5610
6 pfu of HSV-1 added
for 1 h to the AC was used in all subsequent experiments. This
infectious dose corresponded to a multiplicity of infection (MOI) of
approximately 5 in a monolayer culture in a 35-mm-diameter
dish, and did not exhibit unwanted stimulatory effects on the
TGEs due to serum components present in the virus stocks.
Replacement of the TG medium in the AC by serum-containing
media stimulated the outgrowth of glial cells or fibroblasts into the
AC and occasionally led to the contraction and partial detachment
of the explants (data not shown).
As shown in Figure 2B, the diffusion barrier proved to be tight,
effectively inhibiting the nonspecific infection of cells that
surrounded the explant, and were in direct contact with the inner
rim of the glass cylinder. However, EGFP expression in the TGEs
was unexpectedly poor. At 24 hpi, less than half of the axonally-
infected cultures contained single EGFP-positive cells. Staining of
the AC with DiI immediately after infection showed that EGFP
expression was restricted to just a few isolated neurons (Figure 2B).
Less than 2% of DiI-positive neurons (2 out of 127 neurons) were
found to be EGFP-positive (Figure 2C).
The low number of reporter protein expressing neurons in
cultures axonally-infected with HSV-1 17 CMV-IEproEGFP at 24
hpi prompted us to monitor the kinetics of EGFP expression in
intact TGEs over a longer time period (Figure 2D–F). During the
first 10 days after infection [days post infection (dpi)], the
percentage of cultures containing EGFP-positive cells slowly
increased from approximately 40% on 1 dpi to approximately
70% between 4 and 6 dpi, and decreased thereafter. Between 2
Figure 1. Trigeminal ganglion explant cultures. (A) Scheme of the double chamber system. (B–D) Trigeminal ganglion explant (TGE) cultures
stained with DiI in the axonal compartment (AC) 48 h before imaging: (B) overview and (C, D) typical DiI-positive neurons (solid arrowheads) and
neurites (arrowheads) in the ganglion compartment (GC) and AC shown at higher magnification. DB, diffusion barrier.
doi:10.1371/journal.ppat.1002679.g001
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appeared in approximately 15% of cultures, persisted for a few
days, and disappeared thereafter, indicating a self-limiting
secondary spread of HSV-1 within the TGEs (Figure 2D, F). In
axonally infected TGEs, cell free virus could not be isolated from
the supernatants of the GC (data not shown).
The long-term monitoring of these cultures at weekly intervals
showed that in 10–20% of cultures, low and fluctuating levels of
EGFP-expressing neurons persisted up to 10 weeks postinfection
(wpi); in one culture a plaque-like cluster of infected cells
developed at 9 wpi (Figure 2D). The onset of EGFP expression
in individual axonally-infected neurons was followed up with the
aid of serial photographic documentation. This demonstrated that
the number of EGFP-expressing neurons peaked at 4 dpi, and
then decreased to low and fairly stable levels thereafter (Figure 2E).
Determination of the cumulative number of EGFP-positive
neurons revealed differences in the kinetics of the onset of EGFP
expression, with an approximately fivefold increase in the
cumulative number of positive neurons between 1 and 7 dpi,
and a long-lasting but minimal (i.e., less than 1.1-fold) increase
between 3 and 10 wpi (Figure 2E).
As demonstrated in Figure 2G and H, the spread of the parental
wild-type (wt) strain HSV-1 17syn
+ closely resembled the pattern
of fluorescence observed in HSV-1 17 CMV-IEproEGFP-infected
TGEs. Two days after infection of the AC, single cells or small
plaque-like clusters of HSV-1-infected cells located in the interior
of explants could be detected in a few TGEs (Figure 2G). In
contrast, after direct infection of the GC with 10
4 pfu of HSV-1
17syn
+, spread of HSV-1 into the interior parts of TGEs was
observed, and large areas of HSV-1-positive cells containing
infected glial cells and neurons could be visualized (Figure 2H).
Viral genome and transcript levels in infected TGEs
To further characterize the replication of HSV-1 in TGEs, we
determined viral genome and transcript levels in infected TGEs by
quantitative real-time PCR (qPCR). Infection of the GC with
HSV-1 17syn
+ resulted in the onset of a productive infection of the
TGEs. As compared to 1 hpi (input genomes), the number of
replicated genomes increased exponentially between 12 and 48 hpi
(Figure 3A).
The viral genome and transcript levels in axonally infected
TGEs were analyzed in groups of ten cultures, containing two
explants each. At 6, 24, and 168 hpi with 5610
6 pfu of HSV-1
17syn
+ added to the AC, the median HSV-1 DNA levels in the
explants were approximately 14,000, 17,000, and 21,000 ge-
nomes/TGE, respectively (Figure 3B). Although the HSV-1 DNA
load in individual TGEs varied markedly and the variations
increased with time post infection, there were no significant
differences in viral genome levels in the GC between 6 hpi and 168
hpi (i.e. 7 dpi).
The mode of entry into distal axons and the specificity of this
qPCR-based experimental approach were tested by inhibition of
the microtubule-mediated axonal transport with nocodazole and
application of fusion-deficient virus particles to the AC. The
addition of 10 mM nocodazole to both compartments simulta-
neously with viral infection of the AC led to a highly significant
reduction in viral DNA levels in the explants at 2 hpi (Figure 3C).
Negative effects of the nocodazol treatment on neurites within the
AC were not visible by light microscopy (data not shown).
Infection of the AC with 1610
8 particles of the gH-negative
mutant HSV-1 KOSgH87 purified from the supernatants of
transcomplementing gH-expressing Vero cells (Vero F6gH),
corresponding to 5610
6 pfu on VeroF6gH cells, resulted in
similar genome levels in the GC at 6 hpi to those observed in
TGEs infected with HSV-1 17 syn
+. In contrast, genomes could
not be detected in TGEs after the addition of an identical number
of particles of HSV-1 KOSgH87 purified from the supernatants of
nontranscomplementing Vero cells (corresponding to 5 pfu on
VeroF6gH cells) to the AC (Figure 3D).
Genome levels and the number of primary infected cells in
TGEs were quantified in preparations of dispersed TGEs infected
in the GC and the AC, respectively, in the presence of 50 mg/ml
aciclovir (ACV) and harvested at 2 dpi. After infection of the AC
with 1610
6 pfu of HSV-1 17syn
+, approximately 2,000 HSV-1
genomes/TGE were present in the dispersed cultures. HSV-1
antigen-positive neurons or nonneuronal cells could not be
detected by immunofluorescence. In contrast, infection of the
GC led to the dose-dependent expression of viral antigens in
neurons and nonneuronal cells (Table 1).
Absolute and relative levels of HSV-1 IE (ICP27/UL54), early/
late (E/L; gB/UL27), and late (L; gC/UL44) transcripts ranged
from 500 to 125,000 copies/TGE and 1.8610
26 to 6610
24 (viral
transcripts/ß-actin transcripts), respectively, at 6, 24 and 168 hpi
(Figure 3E). IE, E/L, and L transcript levels close to the detection
limit of reverse transcription (RT)-PCR were detectable in few
cultures at 6 hpi, while thereafter there were moderate but
significant increases in lytic transcript levels. Lytic transcripts were
present in most cultures at 24 hpi and in approximately half of the
cultures at 168 hpi. However, the onset of lytic gene expression in
axonally-infected TGEs was remarkably low relative to the high
genome levels present in the GC.
In contrast to lytic transcripts, high levels of the 2.0-kb major
LAT transcript were present in all TGEs selectively infected via
distal axons at 24 and 168 hpi. Between 24 and 168 hpi, LAT
Figure 2. Protein expression and spread of HSV-1 in infected TGEs. (A) Infection of the GC with HSV-1 17 CMV-IEproEGFP. TGEs were
infected with 1610
6 pfu, and stained in the AC with DiI at 1 hpi. At 24 hpi, DiI-specific (A, top right) and EGFP-specific (A, middle right) fluorescence
was monitored in intact cultures. The arrowhead indicates a typical EGFP-expressing, DiI-positive neuron depicted at higher magnification at the right
margin. A merged image of DiI- and EGFP-specific fluorescence is also shown (A, bottom right). (B) Infection of the AC with HSV-1 17 CMV-IEproEGFP.
EGFP expression in single neurons at 48 hpi with HSV-1 17 CMV-IEproEGFP. TGEs were infected in the AC with 5610
6 pfu and stained with DiI at 1
hpi. A typical EGFP- and DiI-positive neuron is indicated by an arrowhead and depicted at higher magnification in the right-hand image. (C)
Percentages of DiI/EGFP-double positive neurons. TGEs were either infected in the GC or in the AC with HSV-1 17 CMV-IEproEGFP and co-stained with
DiI as given in (A,B). At 24 hpi, the numbers of EGFP and DiI-positive neurons in intact TGEs were determined microscopically. (D) Percentages of TGEs
containing EGFP-positive (pos.) cells (white bars) and plaque-like clusters of EGFP-positive cells (EGFP-pos. plaques) (black bars). TGEs (n=23) were
axonally-infected with 5610
6 pfu of HSV-1 17 CMV-IEproEGFP and monitored daily from 1 to 10 dpi, and from 3 to 10 wpi. (E) Time kinetics of EGFP
expression in neurons. Reporter gene expression in the TGEs shown in (D) was documented photographically at the time points indicated. Individual
EGFP-positive neurons were identified, and the total (black bars) and cumulative (white bars) numbers of EGFP-positive neurons were determined. (F)
Plaque-like cluster of EGFP-positive cells in an axonally-infected TGE at 5 dpi. EGFP-positive cells (triangle) and typical, EGFP-positive neurites (arrow
heads) are indicated. (G) Detection of HSV-1-positive cells in cryosections of infected TGEs. TGEs were infected in the AC with 5610
6 pfu of HSV-1
17syn
+. HSV-1-positive cells were detected at 2 dpi by immunofluorescence using a polyclonal antibody against HSV-1 (green), nuclei were stained
with 49,6-diamidino-2-phenylindole (blue). (H) TGEs were infected in the GC with 10
4 pfu of HSV-1 17syn
+, and cultures were fixed and stained at 2
dpi, as given above. A typical HSV-1-positive neuron is shown at higher magnification in the inset image; the neurite is indicated by the arrowhead.
doi:10.1371/journal.ppat.1002679.g002
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LAT at 168 hpi was approximately 1,000-fold higher than that in
ICP27 transcripts (Figure 3E). LAT was also expressed in cultures
infected in the GC with 5610
6 to 8610
3 pfu of HSV-1 17syn
+.A s
compared to TGEs infected in the AC, the specific transcriptional
activity of the LAT gene (transcripts/genome) was 350 to 8,000 -
fold lower in TGEs infected in the GC (Figure 3F).
To exclude strain- and type-specific effects on HSV growth in
TGEs after axonal infection, we repeated the experiments with
clinical isolates of HSV-1 and HSV-2. Again, a synchronous
productive infection with exponentially rising genome levels
between 1 and 3 dpi was not induced in TGEs infected in the
AC (data not shown).
Stimulation of IE gene expression in axonally-infected
neurons with HMBA
Since entry of HSV-1 into the distal axons of sensory neurons
led to a predominantly nonproductive infection, we tested whether
productive infection could be induced by treatment with HMBA, a
known stimulator of HSV-1 IE gene expression [45].
The addition
of 2.5 mM HMBA to the culture medium of axonally-infected
TGEs significantly increased the number of neurons expressing
EGFP under control of the CMV IE promoter and the HSV-1 gD
promoter at 24 hpi (Figure 4A). Quantification of HSV-1 genome
and transcript levels indicated that HMBA treatment induced viral
genome replication in axonally-infected TGEs and significantly
increased the expression of lytic genes at 24 hpi but did not affect
Figure 3. Genome and transcript levels in HSV-1-infected TGEs. (A) Replication of HSV-1 17syn
+ in TGEs infected in the GC. Groups of three
TGEs were infected in the GC with 1610
4 pfu of HSV-1 17syn
+. TGEs were harvested at the time points indicated. DNA extracts were pooled, genome
levels per TGE were quantified by qPCR, and the increase in genome levels relative to that at 1 hpi was determined (replicated genomes). (B) Genome
levels in TGEs infected in the AC with HSV-1 17syn
+. Groups of ten cultures, each containing two TGEs, were infected with 5610
6 pfu of HSV-1 17syn
+,
TGEs of individual cultures were pooled and genome levels/TGE were determined by qPCR at the time points indicated, n.d., No viral genomes
detected by qPCR. The statistical significances of results are indicated as follows: ns (not significant), P.0.05; *P=0.005–0.05; **P=0.0005–0.005;
***P,0.0005. The median genome levels did not differ significantly between 6 hpi and 24 hpi, 24 hpi and 7 dpi, and 6 hpi and 7 dpi (P=0.393, 0.4813,
and 0.2176, respectively; Mann-Whitney test). (C) Effect of nocodazole on the axonal transport of viral particles. Cultures were infected in the AC with
5610
6 pfu of HSV-1 17syn
+ in the presence of 10 mM nocodazole (NOC); mock-treated cultures served as controls. TGEs were harvested at 2 hpi, and
genome levels were determined by qPCR, n.d., No viral genomes detected by qPCR. Differences in genome levels between NOC-treated and
untreated cultures at 2 hpi were highly significant (P=0.0002; unpaired t test with Welch correction). (D) Infection of the AC with the fusion-deficient,
gH-negative mutant HSV-1 KOSgH87. Infection of the AC was performed with 1610
8 particles of HSV-1 KOSgH87. The virus was purified using a
saccharose gradient from the supernatants of transcomplementing VeroF6gH cells (DgH/VeroF6gH) (corresponding to 5610
6 pfu on VeroF6gH cells)
and of noncomplementing Vero cells (DgH/Vero) (corresponding to 10 pfu on VeroF6gH cells). Genome levels were determined by qPCR at 6 hpi. (E)
Transcript levels in TGEs axonally-infected with HSV-1 17syn
+. Groups of ten cultures, each containing two TGEs, were infected in the AC with
5610
6 pfu. IE (ICP27), E/L (UL27), L (UL44), and LAT transcripts were quantified by RT-PCR and normalized to b-actin transcript levels. Transcript levels
at 6, 24, and 168 hpi (7 dpi) are shown, n.d., No viral transcripts detected. The statistical significances of differences in median transcript levels
between 6 and 24 hpi, 24 and 168 hpi, and 6 and 168 hpi are indicated (ICP27: P=0.0068, 0.8798, and 0.0011, respectively; UL27: P=0.0433, 0.1124,
and 0.0001, respectively; UL44: P=0.1230, 0.0021, and ,0.0001, respectively; LAT: P,0.0001, ,0.0001, and ,0.0001, respectively; Mann-Whitney
test). (F) Specific transcriptional activity of the LAT gene in TGEs infected in the GC and AC, respectively. Groups of four TGEs were infected in the GC
with different infectious doses of HSV-1 17syn
+ as indicated. A group of ten TGEs was infected in the AC with 5610
6 pfu. At 7 dpi, LAT copies and viral
genomes/TGE were quantitated by qPCR, and the mean ratio of LAT copies/HSV-1 genomes was determined. Data are mean and SD values.
doi:10.1371/journal.ppat.1002679.g003
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genome levels in HMBA-treated cultures were approximately
1,000-fold higher than in controls (Figure 4C). Monitoring of
intact cultures demonstrated that HMBA strongly induced
productive HSV-1 infection in non-neuronal cells. At 8 dpi,
approximately 40% of the explants showed signs of massive viral
spread (Figure 4D). When HMBA was added at 7 dpi to TGEs
axonally infected with HSV-1 17 CMV-IEproEGFP, no effect on
the number of EGFP-expressing cells was observed (data not
shown). In order to analyze the effect of HMBA on the release of
cell free infectious virus into the culture supernatants, we infected
TGEs with 1610
4 pfu HSV-1 17 gDproEGFP in the GC using
culture media without CMC and HSV-1 antiserum. As compared
to nontreated explants, HMBA-treatment led to an approx. 30-
fold increase in the median levels of cell free infectious virus in the
supernatants at 4 dpi. The number of infectious particles released
by repeated freeze-thawing of explants was approximately 10-fold
higher in HMBA-treated cultures (Figure 4E).
Transactivation of HSV-1 in axonally-infected neurons by
co-infection of the GC with HSV-1 helper virus
We also tested whether genome replication and the expression
of lytic genes in axonally-infected neurons could be induced by
simultaneous co-infection of the GC with a helper virus. To this
end we established a method for quantifying HSV-1 helper-
virus-induced transcriptional transactivation and genome repli-
cation after the selective entry of HSV-1 reporter virus via distal
axons. Cultures were infected in the AC with replication-
competent EGFP-expressing HSV-1 mutants, whereas the GC
was incubated with the spread-deficient gH-negative mutant
HSV-1 KOS gH87. The use of a spread-deficient, gH-negative
HSV-1 helper virus limited transactivation to those cells
primarily infected by the helper virus and allowed to us to
specifically follow up the replication and reporter gene expres-
sion of HSV-1 genomes present in sensory neurons after entry
within the AC.
In contrast to infection of the AC with 5610
6 pfu of HSV-1 17
CMV-IEproEGFP only (see above), EGFP expression in TGEs
was reliably induced by simultaneous co-infection of the GC with
5610
6 pfu of the helper virus HSV-1 KOS gH87. Staining of the
AC with DiI immediately after infection with HSV-1 demonstrat-
ed that at 24 hpi, most EGFP-expressing cells exhibited a typical
neuronal morphology and were stained by DiI (Figure 5A),
indicating the occurrence of transactivation of silent HSV-1
infection in neurons. The number of EGFP-expressing cells was
approximately 30-fold higher in TGEs co-infected with HSV-1
helper virus (Figure 5B).
EGFP DNA and RNA levels were determined by qPCR to
quantify the transactivation of the reporter viruses by the HSV-1
helper virus. The simultaneous co-infection of the GC with
5610
6 pfu of HSV-1 KOS gH87 led to an approximately 20-fold
increase in the genome levels of HSV-1 17 CMV-IEproEGFP in
axonally-infected TGEs at 24 hpi (Figure 5C). Serial fivefold
dilution of the helper virus revealed that a significant induction of
reporter virus replication was still achieved by adding 2610
5 pfu
helper virus to the GC.
To estimate the ratio of helper to reporter virus needed for
transactivation, helper virus genome levels resulting from co-
infection of the GC were quantified. Approximately 40,000 HSV-
1 genomes/TGE were detected by qPCR in cultures immediately
harvested after infection of the GC with 2610
5 pfu of HSV-1
KOS gH87 helper virus (i.e., the lowest amount of helper virus
able to significantly transactivate reporter virus; see above).
Comparable to what was observed with HSV-1 17syn
+, infection
of the AC with 5610
6 pfu of HSV-1 17 CMV-IEproEGFP
reporter virus resulted in mean levels of approximately 10,000
HSV-1 genomes/TGE at 6 hpi. This corresponds to an overall
ratio of helper to reporter virus genomes in co-infected TGEs of
approximately 4. Considering that the HSV-1 added to the GC
also infects nonneuronal cells (Figure 2A), that only a subfraction
of axonally-infected neurons may be directly accessible to the
spread-deficient helper virus in en-bloc-cultivated TGEs, and that
the genome/pfu ratio of the helper virus preparation used was
approximately 30, the actual ratio of helper to reporter virus
needed to transactivate HSV-1 in axonally-infected neurons is
probably much lower.
Quantification of transcript levels showed that simultaneous co-
infection of the GC with HSV-1 helper virus strongly increased
EGFP transcript levels at 24 hpi with HSV-1 17 CMV-
IEproEGFP and HSV-1 17 gDproEGFP (Figure 5D). As observed
for the induction of genome replication, at least 2610
5 pfu of
helper virus needed to be applied to the GC to achieve a
significant transactivation of EGFP expression in cultures
axonally-infected with HSV-1 17 CMV-IEproEGFP (data not
shown).
In order to further elucidate the mechanism underlying helper-
virus-induced HSV-1 IE gene transactivation in axonally-infected
TGEs, reporter gene expression in HSV-1-IE4proEGFP-infected
cultures was determined in the absence of de novo protein synthesis
at 6 hpi. As shown in Figure 5E, low levels of EGFP expression
were detected in most of the cycloheximide (CHX)-treated
cultures without helper virus. The simultaneous addition of
5610
6 pfu of helper virus significantly increased the EGFP
expression, indicating that transactivation of reporter gene












6 pfu 1,835 -/41,000 -/445
GC 1610
6 pfu 20,200 392/46,000 48/500
GC 1610
5 pfu 6,750 34/35,000 3/549
GC 1610
4 pfu 3,840 1/41,000 -/589
aTGEs were infected either in the axonal or ganglion compartment (AC, GC).
bCultures were infected with HSV-1 17syn
+ in the presence of 50 mg/ml ACV, harvested at 2 dpi and dispersed.
cGenome levels per dispersed TGE were quantified by qPCR (mean of three experiments).
d,eHSV-1-positive cells and neurons per dispersed TGE were detected and quantified by immunofluorescence with a HSV-1-specific rabbit antiserum (d), a monoclonal
antibody against the 200 kD neurofilament marker (e) and DAPI (d,e) (mean of three experiments).
doi:10.1371/journal.ppat.1002679.t001
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PLoS Pathogens | www.plospathogens.org 7 May 2012 | Volume 8 | Issue 5 | e1002679Figure 4. Stimulation of productive HSV-1 infection by HMBA. (A) EGFP expression in neurons in the AC at 24 hpi with 5610
6 pfu of HSV-1 17
CMV-IEproEGFP and HSV-1 17 gDproEGFP in the presence of 2.5 mM HMBA. Mock-treated cultures are shown as controls. n.d., No EGFP-positive
neurons detected. The statistical significances of variations in the median number of EGFP-positive neurons in HMBA-treated cultures relative to
mock-treated cultures are indicated (HSV-1 17 CMV-IEproEGFP, P=0.0017; HSV-1 17 gDproEGFP, P=0.0132; Mann-Whitney test). (B) Effect of HMBA
on HSV-1 transcript levels in axonally-infected TGEs at 24 hpi. TGEs were infected in the AC with 5610
6 pfu of HSV-1 17 gDproEGFP. The statistical
significances of differences in median transcript levels are indicated (ICP27, P=0.0089; UL27, P=0.0185; UL44, P=0.0355; LAT, P=0.1051; Mann-
Whitney test). (C) Effect of HMBA on HSV-1 genome levels in axonally-infected TGEs. Groups of ten TGEs were infected in the AC with 5610
6 pfu of
HSV-1 17 gDproEGFP in the presence of 2.5 mM HMBA; mock-treated cultures served as controls. Genome levels were determined by qPCR at 24 hpi
and 7 dpi. The statistical significances of differences in median genome levels are indicated (24 hpi, P=0.0115; 7 dpi, P=0.0002; Mann-Whitney test).
Data are mean and SD values. (D) Spread of HSV-1 in axonally-infected TGEs in the presence of HMBA. TGEs were infected in the AC with 5610
6 pfu of
HSV-1 17 gDproEGFP in the presence of 2.5 mM HMBA and monitored daily for EGFP expression. The pattern of fluorescence in a culture with
massive viral spread is shown at 2, 5, and 8 dpi (d2, d5, and d8, respectively). The bottom-right image depicts a group of HSV-1 infected nonneuronal
cells at 8 dpi. (E) Effect of HMBA on the release of cell free virus. TGEs were infected in the GC with 1610
4 pfu of HSV-1 17 gDproEGFP in the presence
or absence of 2.5 mM HMBA as indicated in culture medium without CMC and HSV-1 antiserum. At 4 dpi, supernatants (supernatant GC) and TGEs
were harvested and virus was titrated. Infectious virus was liberated from TGEs by repeated freeze-thawing in 100 ml PBS (TGE lysates).
doi:10.1371/journal.ppat.1002679.g004
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PLoS Pathogens | www.plospathogens.org 8 May 2012 | Volume 8 | Issue 5 | e1002679Figure 5. Transactivation of HSV-1 in axonally-infected TGEs by infection of the GC with HSV-1 helper virus. (A) Effect of helper virus
on EGFP expression in TGEs infected in the AC with HSV-1 17 CMV-IEproEGFP. TGEs were co-infected with 1610
6 pfu of the gH-negative, spread-
deficient mutant HSV-1 KOS gH87 in the GC and 5610
6 pfu of HSV-1 17 CMV-IEproEGFP in the AC. At 1 hpi, cultures were stained with DiI in the AC.
The arrowhead indicates a typical DiI and EGFP double-positive neuron depicted at higher magnification in the right-hand images. (B) Effect of helper
virus on EGFP expression in axonally-infected neurons. The numbers of positive neurons/culture infected in the AC with 5610
6 pfu of HSV-1 17
CMVpro-IE EGFP and co-infected in the GC with 5610
6 pfu of HSV-1 KOS gH87 (DgH) or mock-infected are given. Differences were highly significant
(P=0.0003, unpaired t test with Welch correction). (C) Effect of helper virus on genome replication of HSV-1 after infection of the AC. Groups of ten
cultures were infected in the AC with 5610
6 pfu of HSV-1 17 CMV-IEproEGFP. The GC was co-infected with varying amounts of HSV-1 KOS gH87, as
indicated. TGEs were harvested at 24 hpi with the helper virus, reporter virus genome levels were quantified by qPCR, and the increase of reporter
virus genome levels relative to controls was calculated. The significances of helper-virus-induced increases in the median genome level of reporter
virus genomes are indicated (5610
6 pfu helper virus, P,0.0001; 1610
6 pfu helper virus, P=0.0021; 2610
5 pfu helper virus, P=0.0015; 4610
4 pfu
helper virus, P=0.4359; Mann-Whitney test). Data are mean and SD values. (D) Reporter gene expression 24 h after co-infection of the GC with HSV-1
helper virus. Cultures were infected with 5610
6 pfu of HSV-1 17 CMV-IEproEGFP, and HSV-1 17 gDproEGFP in the AC. Groups of ten cultures were co-
infected with 5610
6 pfu of HSV-1 KOS gH87 in the GC; cultures not infected with helper virus served as controls. The significances of differences in
the relative transcript levels are indicated (HSV-1 CMV-IEpro EGFP, P,0.0001; HSV-1 gDproEGFP, P,0.0001; unpaired t test with Welch correction). (E)
Helper-virus-induced transcriptional transactivation of IE gene expression in the absence of de novo protein synthesis. Cultures were infected in the
AC with 5610
6 pfu of HSV-1 17 IE4proEGFP in the presence of 50 mg/ml CHX. Groups of ten cultures were co-infected in the GC with 5610
6 pfu of
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occurred directly (i.e., by incoming helper virus particles and in the
absence of de novo protein synthesis).
We also investigated whether the addition of HSV-1 helper
virus to axonally-infected cultures was able to transactivate
reporter virus genomes at 7 dpi (i.e., after the establishment of
an LAT-positive, silent infection). These experiments showed that
the HSV-1 reporter virus was refractory to transactivation by
HSV-1 helper virus at 7 dpi. Infection of the GC with HSV-1
KOSgH87 did not significantly increase reporter virus genomes or
gene expression in explants axonally-infected with HSV-1 17
CMV-IEproEGFP (Figure 5F, G), or directly transactivate IE gene
expression in HSV-1-17-IE4proEGFP-infected cultures in the
presence of CHX (Figure 5H).
Role of VP16 in the induction of IE gene expression by
HSV helper virus
The transactivation of the ICP4 promoter in axonally-infected
and CHX-treated cultures by simultaneous infection of the GC
with HSV-1 helper virus suggested a direct VP16-dependent
transcriptional activation of IE gene expression. To study the role
of VP16, we repeated the experiments using the VP16AD-negative
mutant HSV-1 KOS RP5 as a helper virus to infect the GC. The
corresponding revertant HSV-1 KOS RP5R served as a control
[46]. The number of particles of HSV-1 KOS RP5 used to infect
the GC was adjusted to the number of particles present in
5610
6 pfu of the HSV-1 KOS RP5R preparation. Following
axonal infection of TGEs with HSV-1 IE4proEGFP in the
presence of CHX, IE gene expression was significantly increased
by infection of the GC with HSV-1 KOS RP5R, whereas the
addition of RP5 did not lead to a significant transcriptional
transactivation of the reporter gene at 6 hpi (Figure 6A). When
added to the GC in the absence of CHX at a concentration of 10
8
particles, both HSV-1 KOS RP5 and RP5R were able to
significantly transactivate IE gene expression of the reporter virus
at 6 hpi (Figure 6B). In agreement with this finding, a significant
increase of reporter virus genomes was observed at 24 hpi after the
addition of 10
8 particles of HSV-1 KOS RP5 and RP5R helper
viruses. Serial ten-fold dilution of the helper viruses demonstrated
that the efficiency of transactivation by the rescue mutant HSV-1
KOS RP5R was 10 to 100-fold higher as compared to RP5
(Figure 6C).
The ability of HSV-1 KOS RP5 to infect distal axons was also
analyzed. Similar to what was observed in TGEs at 24 hpi with
HSV-1 17syn
+, only basal levels of lytic transcripts were present in
TGEs axonally-infected with HSV-1 KOS RP5, whereas LAT
was expressed at high levels (data not shown). In CHX-treated,
axonally infected TGEs we could not detect significant VP16-
dependent differences in the transcriptional activity of ICP27
between HSV-1 KOS RP5 and RP5R at 6 hpi (Figure 6D). In
contrast, the transcriptional activity of ICP27 in CHX-treated
TGEs infected in the GC was approximately two log-orders higher
in HSV-1 KOS RP5R-infected cultures as compared to HSV-1
KOS RP5 (Figure 6D). Similar differences between HSV-1 KOS
RP5 and RP5R were observed in CHX-treated Vero cell
monolayers at 6 hpi (Figure 6D). As observed with HSV-1
17syn
+, HMBA-treatment led to a significant increase in genome
levels in TGEs axonally infected with HSV-1 KOS RP5 at 24 hpi
(Figure 6E).
Transactivation of HSV-1 by co-infection of the GC with
HSV-2 and PrV helper virus
The HSV-1-independent transactivation of HSV-1 IE gene
expression by co-infection of the GC with the alphaherpesviruses
HSV-2 and PrV was investigated using the HSV-2 strain 333 and
the replication-competent PrV mutant PrV-KaDgGgfp. As
observed with HSV-1, direct addition of HSV-2 to the GC
resulted in exponentially rising genome levels indicative of massive
viral replication in the TGEs, whereas addition of HSV-2 to the
AC did not induce productive infection of the TGEs between 12
hpi and 48 hpi (Figure 7A). The simultaneous addition of
5610
6 pfu of HSV-2 helper virus to the GC of TGEs axonally-
infected with HSV-1 17 CMV-IEproEGFP led to highly
significant increases in HSV-1 genomes and EGFP transcript
levels at 24 hpi (Figure 7 B, C). In contrast to the HSV-1 helper
virus, infection of the GC with the HSV-2 helper virus at 7 dpi of
the AC with HSV-1 17 CMV-IEproEGFP also strongly increased
HSV-1 genomes and EGFP transcripts (Figure 7B, C). In the
absence of de novo protein synthesis, HSV-2 helper virus strongly
transactivated EGFP expression under control of the HSV-1 ICP4
promoter (Figure 7 D).
TGEs were found to be highly susceptible to direct infection of
the GC with PrV. Furthermore, in contrast to HSV-1 and HSV-2,
PrV infection of the AC also led to a rapid, productive spread of
PrV in TGEs (Figure 8A). PrV-KaDgGgfp proved to be a potent
transactivator of HSV-1 IE gene expression in infected neurons.
The simultaneous addition of 5610
6 pfu of PrV to the GC led to a
highly significant increase in HSV-1 ICP27 gene expression at 6
hpi (Figure 8B). As observed with HSV-2 and in contrast to HSV-
1 helper virus, infection of the GC with PrV helper virus at 7 dpi
of the AC with HSV-1 significantly increased HSV-1 IE gene
expression (Figure 8B). Simultaneous co-infection of the GC with
helper virus in the presence of CHX resulted in a significant
increase in the basal level of HSV-1 IE gene expression
(Figure 8C). Additionally, we studied transactivation by PrV
helper virus in TGEs co-infected in the AC with HSV-1 and PrV.
Axonal co-infection of the TGEs resulted in a strong transactiva-
tion of HSV-1 IE gene expression by PrV helper virus at 6 hpi.
Transactivation was abrogated, however, by CHX-treatment of
TGEs (Figure 8D). Thus, in axonally co-infected cultures
transactivation of HSV-1 appears to be dependent on de novo
protein synthesis of PrV.
Discussion
HSV-1 latency and reactivation in vivo result from a complex
interaction between the virus and its host. It is assumed that
immediately after virus entry into the host cell, the tegument
HSV-1 KOS gH87; cultures without helper-virus co-infection served as controls. TGEs were harvested in the AC at 6 hpi and the relative transcript
levels of EGFP were determined. The statistical significances of differences are indicated (P=0.0003; unpaired t test with Welch correction). (F–H)
Effect of HSV helper virus added to the GC of the AC at 7 dpi. (F, G) Cultures were infected in the AC with 5610
6 pfu of HSV-1 17 CMV-IEproEGFP. At 7
dpi, cultures were infected in the GC with 5610
6 pfu of HSV-1 KOS gH87, cultures without helper-virus infection served as controls. At 24 h after the
addition of helper virus, TGEs were harvested and genome levels of the reporter virus (F) and EGFP transcript levels were determined. There were no
significant differences in reporter virus genome and transcript levels (genomes, P.0.9999, Mann-Whitney test; transcript levels, P=0.7609, unpaired t
test with Welch correction). (H) Cultures were infected in the AC with 5610
6 pfu of HSV-1 17 IE4proEGFP. At 7 dpi, cultures in the AC were either
infected in the GC with 5610
6 pfu of HSV-1 KOS gH87 or mock-infected in the presence of CHX, and EGFP transcript levels were determined 6 h after
addition of the helper virus. There were no significant differences in transcript levels (P=0.8269, unpaired t test with Welch correction).
doi:10.1371/journal.ppat.1002679.g005
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PLoS Pathogens | www.plospathogens.org 10 May 2012 | Volume 8 | Issue 5 | e1002679Figure 6. Infection of TGEs by the VP16AD-deficient mutant HSV-1 KOS RP5. (A) Transactivation of HSV-1 IE gene expression by HSV-1 KOS
RP5 in the absence of de novo protein synthesis. Cultures were infected in the AC with 5610
6 pfu of HSV-1 17 IE4proEGFP in the presence of 50 mg/
ml CHX. Groups of ten cultures were co-infected in the GC with identical numbers of particles of HSV-1 KOS RP5 or the revertant HSV-1 KOS RP5R
(1610
8 particles, corresponding to 5610
6 pfu of HSV-1 KOS RP5R). Cultures without helper-virus co-infection served as controls. Cultures were
harvested at 6 hpi, and the relative transcript levels of EGFP were determined. The statistical significances of differences in the mean relative
transcript levels are indicated (mock vs. HSV-1 KOS RP5, P=0.8352; mock vs. HSV-1 KOS RP5R, P,0.0001; HSV-1 KOS RP5 vs. HSV-1 KOS RP5R
P,0.0001; unpaired t test with Welch correction), ns (not significant). (B) Transactivation of HSV-1 IE gene expression by HSV-1 KOS RP5 without
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regulatory circuit controlling the lytic/latent decision. If the
transactivation of IE genes by the VP16-induced complex is
insufficient, this may diminish lytic gene expression in the infected
neuron and favor the establishment of latency [5,47].
As originally supposed by Roizman and Sears [48], a lack of
retrograde axonal transport of VP16 upon entry into the distal
axons could be responsible for the poor onset of IE gene
expression in neurons in vivo. By contrast, infection of the soma
may enable VP16 to reach the nucleus and to initiate a lytic
infection of the neuron, as observed in neuronal cultures non-
selectively infected in vitro.
In addition, transactivation by residual VP16 reaching the soma
of the axonally infected neuron may be blocked. Modulation of the
function of VP16 by other components of the HSV-1 outer
tegument layer might contribute to the insufficiency of transacti-
vation of IE gene expression in axonally-infected neurons. The
tegument proteins UL46 and UL47, which reportedly increase the
activity of VP16 [49,50], are predominantly lost from capsids
during retrograde axonal transport [22]. In addition, residual
VP16 activity may be blocked by the cytoplasmic sequestration of
HCF-1 in unstimulated neurons [51], and the interaction of HCF-
1 with the basic leucine zipper proteins, Luman and Zhangfei [52–
54].
Various cell culture systems have been used to study the
establishment of and reactivation from latency at the molecular
level in vitro [5]. If a missing or strongly reduced axonal transport
of VP16 is important for the lytic/latent decision in the infected
neuron, the ability of HSV-1 to induce lytic gene expression in
neurons should differ with the site of viral entry. Specifically, the
selective infection of distal axons should predispose neurons to a
nonproductive HSV-1 infection. To our knowledge, and contrary
to this assumption, differences specific to the site of entry in the
ability of HSV to cause productive infection of neurons remain
unknown. The selective entry of HSV-1 into the axons of
dissociated DRGs in vitro has been reported to result in the
productive infection of neurons, and consequently in the
progressive spread of HSV throughout the cultures [42,55].
While a predominantly nonproductive HSV-1 infection can be
spontaneously established in neuronal cultures [56], acute lytic
infection must usually be suppressed for some time to enable the
efficient establishment of latent infection in vitro, especially if
infections are performed at a high MOI [57–61]. As shown by
Bertke et al. [62] neuronal factors may have a significant impact
on the relative permissiveness for productive infection. Thus, adult
murine A5-positive sensory neurons are nonpermissive for
productive infection with HSV-1 in vitro. To our knowledge,
chicken trigeminal neurons have not been tested for the expression
of the A5 (Galb1-4GlcNAc-R) epitope. As additional markers of
adult murine trigeminal neurons preferentially harboring latent
HSV-1, the calcitonin-gene related peptide (CGRP) and the high
affinity NGF receptor (TrkA) have been described [63]. The
majority of neurons in the adult chicken trigeminal ganglion are
reactive for the calcitonin-gene related peptide (CGRP) [64].
Furthermore, basic characteristics of neurotrophins and their
receptors in sensory neurons appear to be well preserved between
mammals and the chick, e.g., the same genes are found and
expressed with shared common features in different neuron
populations during development. TrkA is expressed at high levels
in the embryonic chicken TG [65].
Analysis of the viral transcript and genome levels in HSV-1
infected embryonic chicken TGEs between 6 hpi and 7 dpi
revealed that the infection of free distal axons spontaneously
resulted in a largely nonproductive HSV-1 infection that was
characterized by stationary genome levels with a median of
approximately 10,000 to 20,000 genomes/TGE infected with
5610
6 pfu HSV-1 17syn
+, the expression of low and fluctuating
levels of lytic transcripts, and the prominent expression of LAT at
24 hpi and thereafter. A general lack of susceptibility of the organ
model to HSV-1 is unlikely to account for this observation.
Previous studies showed that neuronal embryonic chicken tissues
are permissive for HSV-1, and are a suitable model system for the
analysis of neurotropic alphaherpesviruses [44,66]. Our data
confirm that HSV-1 can efficiently infect the distal axons of
embryonic chicken TGEs. We estimate that the addition of HSV-1
at saturating infectious doses to the AC results in stable mean
levels of 70–210 HSV-1 genomes per neuron with neurites
reaching the AC. This is highly consistent with levels of
approximately 70 and 180 viral genomes per latently infected
LAT-negative and LAT-positive neuron in the mouse model
reported by Chen et al. [67]. Fusion-incompetent viral particles
added to the AC of embryonic chicken TGEs were not transported
in a retrograde direction to the GC. Thus, in agreement with
earlier studies, HSV-1 enters the distal axons of embryonic
chicken TGEs by direct fusion with the axonal membrane, and not
via endocytotic uptake [22,68–70].
If this is correct, a lack of axonal transport of VP16 should result
in a similar pattern of lytic gene expression in neurons axonally-
infected with wt HSV and a VP16AD-negative mutant. In fact,
ICP27 transcript levels in CHX-treated TGEs axonally infected
inhibition of de novo protein synthesis. Cultures were infected in the absence of CHX with HSV-1 KOS RP5 and RP5R as given above (Figure 6A) and
the relative transcript levels of EGFP were determined at 6 hpi. The statistical significances of differences in the mean relative transcript levels are
indicated (mock vs. HSV-1 KOS RP5, P,0.0001; mock vs. HSV-1 KOS RP5R, P,0.0001; HSV-1 KOS RP5 vs. HSV-1 KOS RP5R P=0.6874; unpaired t test
with Welch correction), ns (not significant). (C) Transactivation of HSV-1 genome replication by HSV-1 KOS RP5. Groups of ten cultures were infected
in the AC with 5610
6 pfu of HSV-1 17 gDproEGFP. The GC was co-infected with different infectious doses of HSV-1 KOS RP5 and RP5R as indicated.
TGEs were harvested at 24 hpi with the helper virus, reporter virus genome levels were quantified by qPCR, and the increase of reporter virus genome
levels relative to controls was calculated. The significances of helper-virus-induced increases in the mean genome level of reporter virus genomes are
indicated (HSV-1 KOS RP5: 1610
8 particles, P=0.0108; 1610
7 particles, P=0.0572; 1610
6 particles, P=0.1592; HSV-1 KOS RP5R: 1610
8 particles,
P,0.0001; 1610
7 particles, P=0.0038; 1610
6 particles, P=0.0026; unpaired t test with Welch correction). Data are mean and SD values. (D) Specific
transcriptional activity of the ICP27 gene in cultures infected with HSV-1 KOS RP5 and RP5R in the absence of de novo protein synthesis. Vero cells
(three independent experiments) were infected with an identical number of particles of HSV-1 KOS RP5 and RP5R at the MOI indicated, groups of 4
and 10 CHX-treated TGEs were infected in the GC and AC, respectively, with the number of particles indicated, and harvested at 6 hpi. Copy numbers
of the ICP27 transcript and viral genomes/TGE were quantitated by qPCR, and the ratio of ICP27 transcript copies/HSV-1 genomes was determined.
The significance of differences in the specific transcriptional activity of ICP27 are indicated (Vero cells: HSV-1 KOS RP5 vs. RP5R infected at a MOI 10
and 1, P=0.0001; TGEs infected in the GC: HSV-1 KOS RP5 vs. RP5R infected with 10
6 and 10
7 particles, P=0.0001; TGEs infected in the AC: HSV-1 KOS
RP5 vs. RP5R, P=0.3242; unpaired t test with Welch correction). Data are mean and SD values, ns (not significant). (E) Effect of HMBA-treatment on
genome levels in TGEs infected in the AC with HSV-1 KOS RP5. Cultures were infected in the AC with 1610
8 particles of HSV-1 KOS RP5 in the absence
or presence of 2.5 mM HMBA. Genome levels were determined at 24 hpi. The statistical significances of differences in the mean genome level is
indicated (P=0.0363; unpaired t test with Welch correction). Data are mean and SD values.
doi:10.1371/journal.ppat.1002679.g006
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levels of lytic transcripts at 24 hpi were found to be comparable in
cultures infected with HSV-1 17syn
+ and various EGFP-express-
ing HSV-1 17 mutants, HSV-1 KOS RP5 and RP5R (data not
shown). Thus, at least in the early phase of infection, conspicuous
VP16-dependent differences in lytic viral transcript levels were not
evident in axonally-infected TGEs. Proenca et al. [71] recently
demonstrated that HSV-1 IE gene expression by a VP16-
independent mechanism can precede the establishment of latency
in sensory neurons. In addition, we also found similar levels of
LAT expressed by HSV-1 wt virus and the VP16AD-negative
mutant in axonally-infected TGEs.
In the absence of functional VP16, HMBA has been described
to enhance IE gene expression and lytic growth of HSV-1,
especially if cells are infected at low MOI [45,72]. The exact mode
of action of the cytodifferentiating agent HMBA on HSV-1 growth
is not fully understood. HMBA induces the differentiation of
murine erythroleukemia cells (MELC) and other transformed cells
to a less transformed phenotype [73]. Comparison of the effects of
various other agents known to promote the differentiation of
MELCs demonstrated that some of these substances complement
the growth of VP16-deficient HSV-1 whereas others antagonize
the effect of HMBA [74]. HMBA-treatment also increases the
replication of VP16-positive HSV-1 and HSV-2 in epidermal and
neuronal cells [75], and the oncolytic activity of a gamma1-34.5-
negative HSV-1 mutant in oral squamous carcinoma cells [76].
Accordingly, HMBA treatment significantly increased the
expression of lytic genes in TGEs axonally-infected with the
VP16AD-negative mutant HSV-1 KOS RP5. HMBA treatment
also restored the ability of VP16-competent HSV-1 strains to
initiate a productive infection of sensory neurons and stimulated
viral spread within nonneuronal cells. In TGEs axonally-infected
with the spread-deficient mutant HSV-1 KOS gH87, HMBA
treatment significantly enhanced the expression of lytic genes (data
Figure 7. Transcriptional transactivation of HSV-1 IE gene expression by HSV-2 helper virus. (A) Replication of HSV-2 in TGEs. Groups of
three TGEs were either infected in the AC with 5610
6 pfu of HSV-2 333 (grey bars) or in the GC with 10
4 pfu of HSV-2 333 (black bars), and harvested
at the time points indicated. DNA extracts were pooled, genome levels were determined by qPCR, and the increase in genome levels relative to 1 hpi
was calculated. (B, C) Transactivation of HSV-1 by HSV-2 infection of the GC. TGEs were infected in the AC with 5610
6 pfu of HSV-1 CMV-IEproEGFP,
and infected either simultaneously or at 7 dpi in the GC with 5610
6 pfu of HSV-2 333. Cultures were harvested at 24 hpi after the addition of HSV-2 to
the GC, and HSV-1 genome (B) and relative EGFP transcript levels (C) were determined. Cultures not infected with helper virus served as controls. The
statistical significances of differences in the transcript levels are indicated (simultaneous infection, P,0.0001; addition of PrV at 7 dpi, P,0.0001;
Mann-Whitney test). (D) Transcriptional transactivation of HSV-1 by co-infection of the GC with HSV-2 in the presence of CHX. TGEs were infected in
the AC with 5610
6 pfu of HSV-1 17 IE4proEGFP in the presence of CHX and either co-infected in the GC with 5610
6 pfu of HSV-2 333 or mock-
treated. Cultures were harvested at 6 hpi and EGFP transcript levels normalized to b-actin transcripts were determined. The statistical significances of
differences in the mean relative transcript levels are indicated (P.0.0001, unpaired t-test with Welch correction).
doi:10.1371/journal.ppat.1002679.g007
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cient transactivation of IE gene expression by VP16 in axonally-
infected neurons.
With respect to the ability of HSV-1 to induce a productive
infection of neurons when added directly to the GC, we reasoned
that silent HSV-1 infection resulting from axonal infection could
be transactivated by the direct co-infection of neurons with HSV-1
helper virus. Our results show that both genome replication of the
reporter virus and reporter gene expression under the control of
HSV-1 IE, E/L, and human CMV (HCMV) IE promoters can be
transactivated by simultaneous infection with a helper virus
introduced into the GC. Quantification of helper and reporter
virus levels in co-infected TGEs indicated that only a few helper
virus particles appear to be sufficient to transactivate the reporter
virus in neurons.
These results further support the hypothesis that the poor
expression of lytic genes after axonal entry is due to low or missing
transactivation by VP16, since helper-virus-induced transactiva-
Figure 8. Transcriptional transactivation of HSV-1 IE gene expression by PrV helper virus. (A) Replication of PrV in TGEs. Groups of three
TGEs were either infected in the AC with 5610
6 pfu of PrV-KaDgGgfp (grey bars) or in the GC with 10
4 pfu of PrV-KaDgGgfp (black bars), and
harvested at the time points indicated. DNA extracts were pooled, genome levels were determined by qPCR, and the increase in genome levels
relative to 1 hpi was calculated. (B) Transcriptional transactivation of HSV-1 by PrV infection of the GC. TGEs were infected in the AC with 5610
6 pfu of
HSV-1 CMV-IEproEGFP, and infected either simultaneously or at 7 dpi in the GC with 5610
6 pfu of PrV-KaDgGgfp. Replication of PrV was suppressed
by the addition of 50 mg/ml ACV to the media. Cultures were harvested at 6 hpi after the addition of PrV to the GC, and relative ICP27 transcript levels
were determined. Cultures not infected with helper virus served as controls. The statistical significances of differences in the transcript levels are
indicated (simultaneous infection, P,0.0001; addition of PrV at 7 dpi, P,0.0001; unpaired t test with Welch correction). (C) Transcriptional
transactivation of HSV-1 by co-infection of the GC with PrV in the presence of CHX. TGEs were infected in the AC with 5610
6 pfu of HSV-1 17 CMV-
IEproEGFP in the presence of CHX and either co-infected in the GC with 5610
6 pfu of PrV-KaDgGgfp or mock-treated. Cultures were harvested at 6
hpi and ICP27 transcript levels normalized to b-actin transcripts were determined. The statistical significances of differences in the mean relative
transcript levels are indicated (P=0.0186, unpaired t test with Welch correction). (D) Transcriptional transactivation of HSV-1 by co-infection of the AC
with PrV. TGEs were infected in the AC with 2.5610
6 pfu of HSV-1 17 syn
+ in the presence or absence of CHX and co-infected in the AC with
2.5610
6 pfu of PrV-KaDgGgfp or mock-treated as indicated. Cultures were harvested at 6 hpi and ICP27 transcript levels normalized to b-actin
transcripts were determined. The statistical significances of differences in the mean relative transcript levels are indicated (mock+CHX vs. PrV+CHX,
P.0.999; mock+CHX vs. PrV2CHX, P,0.0001; PrV+CHX vs. PrV2CHX, P,0.0001; Mann-Whitney test), ns (not significant).
doi:10.1371/journal.ppat.1002679.g008
Silent HSV Infection of Neurons upon Axonal Entry
PLoS Pathogens | www.plospathogens.org 14 May 2012 | Volume 8 | Issue 5 | e1002679tion of IE gene expression by simultaneous co-infection of the GC
occurred in the absence of de novo protein synthesis, and efficient
transactivation was dependent on the presence of functional VP16
in the HSV-1 helper virus.
The related alphaherpesviruses HSV-2 and PrV also efficiently
transactivated lytic HSV-1 gene expression in axonally-infected
neurons. However, unlike HSV-1 and HSV-2, the lytic gene
expression after axonal entry of PrV is sufficient to initiate a
synchronous, productive infection of neurons. The rapid spread of
PrV in the explants following axonal infection is highly consistent
with its high in vivo pathogenicity, which is substantially greater
than that of HSV [77].
The simultaneous co-infection of the GC with HSV-2 or PrV
was found to directly transactivate HSV-1 IE gene expression in
neurons in the absence of de novo protein synthesis. Transactivation
of HSV-1 IE gene expression is most likely mediated by HSV-2
VP16 and the PrV VP16/pUL48 homologue [78], although it has
been reported that UV-inactivated PrV particles do not transacti-
vate the expression of reporter genes controlled by IE promoters of
HSV-1 or PrV [79,80]. Interestingly, the HSV-2 and PrV but not
HSV-1 helper viruses were still able to efficiently transactivate
HSV reporter virus gene expression at 7 dpi. It is unclear why
HSV-1 helper virus specifically fails to transactivate HSV-1
genomes in axonally-infected neurons when added after the
establishment of a silent, latency-like infection in the cultures.
However, our finding is in agreement with the results of Su et al.
[81], who reported that HSV-1 genomes in long-term NGF-
differentiated, quiescently-infected PC12 cells become refractory
to superinfection with HSV-1. Mador et al. [82] showed that the
expression of HSV-1 LAT renders neurons resistant to infection
with HSV-1 but not HSV-2, and concluded that protection
against superinfection with HSV-1 may be an important function
of HSV-1 LAT. Since axonally-infected TGEs express high levels
of LAT at 7 dpi, a LAT-dependent mechanism may be responsible
for the HSV-1-specific failure to transactivate silent HSV-1
infection observed in this study. As discussed by Berngruber et
al. [83], protection of the host cell harboring latent virus by
superinfection inhibition is not restricted to bacteriophages but
appears to be a common mechanism in the maintenance of latency
in many viral systems including HSV-1, and may be a driving
force in the evolution of viral latency.
The use of fluorescence microscopy to monitor intact,
axonally-infected TGEs with the replication-competent mutant
HSV-1 17 CMV-IEproEGFP showed that a few isolated neurons
expressed EGFP within the first days after infection. Monitoring
the onset of EGFP expression in individual neurons revealed that
this was associated with an approximately fivefold increase in the
cumulative number of EGFP-positive neurons during the first 10
days after axonal infection. The cumulative number of EGFP-
positive neurons increased at a small but constant rate during
weeks 3–10 after axonal infection. Balliet et al. [84] interpreted
the de novo onset of EGFP expression under the control of the
HCMV IE promoter in latently HSV-1-infected neurons as
spontaneous molecular reactivation, a term coined by Feldman
et al. [85]. Spontaneous molecular reactivation, as observed in
the mouse TG, might reflect asymptomatic viral shedding and
recurrent disease in humans occurring in the absence of known
external stimuli of HSV reactivation [86]. Stochastic spontane-
ous reactivation patterns have also been described in other latent
herpesvirus infections [87]. Since HSV-1 spreads from EGFP-
positive neurons to surrounding nonneuronal cells in a small
proportion of axonally-infected embryonic chicken TGEs, at
least a fraction of the former must have been productively
infected.
Interestingly, after a short period of expansion, the growth of
these plaque-like clusters of infected cells ceased and EGFP-
positive cells finally disappeared again. This is reminiscent of the
results of Barreca and O’Hare [88,89], who reported that HSV-1-
infected MDBK cells develop an interferon-dependent, refractory
state leading to the suppression of viral growth on the one hand
and the persistence of virus in a subpopulation of cells on the
other.
As reported by Camarena et al. [90], continuous NGF-
mediated signaling is required to maintain HSV-1 latency in
primary neuron cultures. The use of serum-free culture media
supplemented with NGF as the only growth factor may thus have
favored the long-term nonproductive infection of neurons
observed in the present study. The presence of fetal calf serum
(FCS) in the culture medium and continuing viral spread from
infected epithelial cells to distal axons instead may enhance the
productive HSV-1 infection of embryonic chicken TGEs [43]. In
the present study we found that treating the cultures with the cell-
differentiation-inducing agent HMBA not only enhanced the
expression of lytic genes in axonally-infected neurons but also
strongly promoted secondary viral spread to the surrounding
neurons and nonneuronal cells. Clearly, differentiation, trophic
state, developmental stage, and age of neurons and nonneuronal
cells significantly impact the outcome of HSV-1 infection in
neuronal organotypic cultures. In particular, even if the vast
majority of neurons become nonproductively infected, conditions
favoring the massive secondary spread of HSV-1 will disrupt the
establishment of a long-lasting latency-like HSV-1 infection as
long as a few productively infected neurons and susceptible cells
are present in the organotypic cultures. Thus, the apparent failure
of HSV-1 to spontaneously establish a latency-like infection upon
axonal infection in earlier studies may also reflect differences in the
endogenous capability of cultures to establish a refractory antiviral
state.
In conclusion, our work provides direct experimental evidence
that HSV-1 entry into the distal axons of sensory neurons is
characterized by a site-of-entry-specific restriction of lytic gene
expression. We consider our observations to be relevant for the
course of natural HSV-1 infection and the underlying mechanism
to be decisive for the establishment of latency. Although the block
to lytic infection is not complete, switching off the transactivation
of IE genes by VP16 is probably an essential first step in the
combinatory circuit that ultimately triggers the establishment of
latency in sensory neurons infected via the physiological route. In
turn, the repression of massive lytic replication in the PNS despite
infection of neurons at a high MOI may enable the host to initiate
an innate immune response and prevent anterograde spread of the
virus until adaptive immune mechanisms have developed [91–93].
In this way, both the efficient establishment of latent infection and




All procedures involving chicken embryos complied with the
relevant national guidelines. Embryonated chicken eggs are not
subject to the restrictions imposed by German laws related to
animal protection. Furthermore, any organ explanted from a
killed animal is not defined as an animal experiment (Tierschutz-
gesetz 17 (1)). For infection experiments, explant cultures were
treated with the virus, and thus no infection of live organisms
occurred. The use of chicken embryos has been approved officially
as an alternative to replace animal experiments, in accordance
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Generation of EGFP-expressing recombinant HSV-1
Cloning of the transfer plasmids. To generate mutant
HSV-1-expressing EGFP under the control of the CMV IE-
promoter, the HSV-1 ICP4 promoter, and the HSV-1 gD
promoter, transfer plasmids with the respective reporter cassettes
inserted between the HSV-1 UL21 and UL22 (gH) genes were
constructed.
The transfer plasmid pUCgHBgl2m_CIE-EGFP, which was
used to generate HSV-1 17 CMV-IEproEGFP expressing EGFP
under the control of the CMV IE promoter, was cloned as follows.
The vector pUCgHBgl2mABS was generated by PCR-mediated,
site-directed mutagenesis of pUCgHBgl2m [94] comprising the
gH coding sequence within the HSV-1 BglIIm fragment (6.4 kb,
from nucleotide positions 41,449–47,855 of the HSV-1 genome;
GenBank accession no. X14112) [95]. pUCgHBgl2mABS con-
tains a unique BclI site immediately downstream of the gH stop
codon (nucleotide position 43,866), a second poly A region derived
from plasmid pEGFP-1 (BD Biosciences Clontech, Heidelberg,
Germany), and a unique SpeI site 59 of the endogenous gH poly A
region. The transfer plasmid pUCgHBgl2m_CIE-EGFP was
obtained by subcloning the 0.79-kb HindIII/XbaI EGFP-coding
fragment of pEGFP-1 into the HindIII/XbaI sites of pVAX1 (BD
Biosciences Clontech) and transferring the 1.45-kb SpeI/XbaI
fragment containing the HCMV major IE promoter region of
pVAX1 and the EGFP coding sequences into pUCgHBgl2mABS.
The transfer plasmid pUCgHBgl2m_IE4-EGFP was construct-
ed to generate HSV-1 17 IE4proEGFP expressing EGFP under
the control of the HSV-1 IE ICP4 promoter. A PCR product
containing a 380-bp fragment of the promoter and the 59-
nontranslated region of ICP4 (positions 131,079–131,458; nucle-
otides 2350 to +30 relative to the transcript start site) [96] was
inserted into pEGFP-1, and the 1.14-kb Spe1/Xba1 ICP4
promoter/EGFP fragment was subcloned into pUCgHBgl2-
mABS.
The transfer plasmid pUCgHBgl2m_gDproEGFP was con-
structed to generate HSV-1 17 gDproEGFP expressing EGFP
under the control of the HSV-1 E/L gD promoter. A PCR
product containing a 461-bp fragment of the promoter and 59-
nontranslated region of gD (positions 137,941–138,402; nucleo-
tides 2392 to +69 relative to the transcript start site) [95] was
inserted into pEGFP-1, and the 1.22-kb Spe1/Xba1 gD promot-
er/EGFP fragment was subcloned into pUCgHBgl2mABS.
Homologous recombination and selection of the
recombinant virus. Recombinant HSV-1 expressing EGFP
was generatedby cotransfecting Vero cells with purified DNAof the
HSV-1 strain 17syn
+ and plasmids pUCgHBgl2m_CIE-EGFP,
pUCgHBgl2m_IE4pro-EGFP, and pUCgHBgl2m_gDproEGFP.
For each construct, several clones of the recombinant viruses (e.g.,
HSV-1 17 CMV-IEpro-EGFP, HSV-1 17 IE4pro-EGFP, and
HSV-1 17 gDpro-EGFP) exhibiting bright autofluorescence were
selected and plaque-purified to homogeneity. The correctness of the
insertion of the reporter protein cassette into the viral genome was
verified by restriction enzyme analysis and DNA sequencing (data
not shown).
Cells, viruses, and chemicals
TGEs and standard cell lines were cultivated at 37uCi na n
atmosphere of 5% CO2 and 100% humidity. Vero and RK13 cells
were grown in minimal essential medium (MEM; Biochrom,
Berlin, Germany) supplemented with 10% v/v FCS and
antibiotic/antimycotic additives (100 mg/ml streptomycin,
100 U/ml penicillin G, and 0.25 mg/ml amphotericin B; Invitro-
gen, Karlsruhe, Germany). TGEs were grown in TG medium
consisting of D-valine-modified MEM (Biochrom) with 5 g/l
glucose, 200 mM L-glutamine (Sigma-Aldrich, Munich, Ger-
many), 50 ng/ml rat NGF 7S (Invitrogen), and antibiotic/
antimycotic additives. The carboxymethylcellulose (CMC)-con-
taining TG medium comprised MEM with 0.5% CMC (Sigma-
Aldrich), 5 g/l glucose (Sigma-Aldrich), 50 ng/ml NGF 7S, 1%
human serum (Harlan Sera-Lab, Loughborough, UK), and
antibiotic/antimycotic additives.
The HSV-1 strain 17syn
+, EGFP-expressing HSV-1 recombi-
nants and HSV-2 333 were propagated on Vero cells, and
infection titers were quantified using a plaque assay.
The gH-negative mutant HSV-1 KOS gH87 in which the
1,790-bp NcoI-XbaI-fragment of the gH gene has been replaced
by the lacZ gene under control of the CMV IE promoter was
kindly provided by P.G. Spear (Chicago, IL, USA). Fusion-
competent stocks of HSV-1 KOS gH87 were propagated and
titrated on gH-expressing VeroF6gH cells kindly provided by A.C.
Minson (Cambridge, UK) [97]. Fusion-deficient virus particles
were collected from the supernatants of nontranscomplementing
Vero cells.
Enrichment and purification of HSV-1 particles from cell-
culture supernatants by ultracentrifugation on a 20% saccharose
cushion was performed as described previously [94].
The VP16AD-negative strain HSV-1 KOS RP5 and the
corresponding revertant RP5R were generated and propagated
as described by Tal-Singer et al. [46], and kindly provided by S.J.
Triezenberg, Van Andel Research Institute, Grand Rapids, MI,
USA. For infection of TGEs, HSV-1 KOS RP5 and RP5R were
grown and titrated on Vero cells.
Using 204-nm latex polystyrene beads (Plano, Wetzlar,
Germany) as a calibration standard, the particle/pfu ratios of
virus stocks of HSV-1 KOS RP5, HSV-1 KOS RP5R, and HSV-1
17syn
+ propagated on Vero cells were determined to be 10,000,
31.5, and 18, respectively. The particle/pfu ratios of purified
particles of HSV-1 KOS gH87 propagated on VeroF6gH and
Vero cells were 15.5 and 2610
7, respectively.
Generation of the EGFP-expressing mutant PrV-KaDgGgfp is
described elsewhere [98], and the virus was propagated on RK13
(rabbit kidney) cells. CHX, nocodazole, acyclovir, HMBA, and
other chemicals used for cell culture were purchased from Sigma-
Aldrich.
Clinical isolates of HSV-1 and HSV-2 were obtained from the
routine diagnostic laboratory of the University Hospital of
Mu ¨nster. Isolates were propagated on Vero cells as described
above.
TG explantation and culture
Day-15 chick embryos were used for the preparation of TGs.
The skull was opened dorsally, the brain removed, and the TG
dissected out and maintained in MEM at 4uC until being used
further. Tissue culture dishes (35 mm in diameter) were coated
with 10 mg/ml gelatin (Biochrom) followed by 20 mg/cm
2 mouse
laminin (Roche, Mannheim, Germany). They were then washed
and dried. The bottom of the coated tissue-culture dishes was
scratched with a pin rake (Tyler Research, Edmonton, Canada) to
form equally placed grooves. A cloning cylinder (Omnilab,
Bremen, Germany) that was 8 mm high, and with an internal
diameter of 8 mm and a wall thickness of 1 mm, was attached to
the center of the culture dish with sterile silicone grease (Bayer,
Leverkusen, Germany), forming inner and outer compartments.
TGEs were fixed to the inner chamber by 1–2 min of air-drying,
and then both compartments were supplied with TG medium and
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fixation, care was taken to ensure that the pole of explants
containing axons projecting to the periphery in vivo faced the inner
rim of the diffusion barrier. Axon penetration from the inner to the
outer compartment was monitored visually prior to infection.
For selective staining of neurons innervating the external
compartment, 5 ml of the retrograde axonal tracer DiI (Vybrant
DiI cell-labeling solution, Invitrogen) was added per milliliter of
culture medium and incubated for 20 min.
Infection of TGEs
Before the selective infection of sensory nerve endings in the
AC, the medium in the GC was replaced by 0.3 ml of CMC-
containing TG medium (as described above). After 30 min, the
virus suspended in 2 ml of TG medium was added to the AC,
where it was incubated for 1 h at 37uC. The virus inoculum was
then removed, the AC washed once with phosphate-buffered
saline (PBS), and CMC-containing TG medium was added. Cross-
contamination by leakage from the AC was avoided by keeping
the fluid level slightly higher in the GC than in the AC.
For nonselective infection of TGEs, the medium in the GC was
carefully aspirated and virus suspension (0.3 ml) was added. At 1
hpi, the virus inoculum was replaced by 0.3 ml of CMC-
containing TG medium.
For infection of the GC with helper virus, the medium of the
inner chamber was carefully aspirated, and 0.3 ml of helper virus
suspension was added. After 45 min, the helper virus inoculum
was replaced by 0.3 ml of CMC-containing TG medium, in which
cultures were incubated at 37uC. To avoid cross-contamination,
co-infection of the AC with reporter virus was performed 20 min
after completing infection of the GC with helper virus and the
addition of CMC-containing TG medium to the GC. At 1 h after
incubation of the AC with 2 ml of reporter virus inoculum at
37uC, the virus inoculum was aspirated from the AC, cultures
were washed once with PBS, and CMC-containing TG medium
was added. The chambers were incubated at 37uC for the
duration of the experiments.
qPCR
Nucleic acid extraction and complementary DNA
synthesis. Chicken TGEs were removed en bloc from culture
dishes using sterile, nucleic-acid contamination-free forceps,
placed immediately in RNAlater stabilization reagent (Qiagen,
Hilden, Germany) and stored according to the manufacturer’s
instructions until being used further. To isolate nucleic acids from
en bloc tissue, cultivated TGEs were dissected and homogenized
in RLT lysis buffer containing b-mercaptoethanol (AllPrep Micro
Kit, Qiagen) using the TissueRuptor system (Qiagen). Genomic
DNA and total RNA were subsequently purified on AllPrep DNA
spin columns and RNeasy MinElute spin columns according to the
manufacturer’s instructions.
Complementary DNA (cDNA) was prepared from total RNA
extracts with the aid of the Superscript III First-Strand Synthesis
System for RT-PCR (Invitrogen), applying 50 ng per reaction of
the random hexamer primers included in the kit. Samples were
treated with RNase H (Invitrogen) to increase the sensitivity of
subsequent PCR steps. Control reactions included samples with
reverse transcriptase omitted.
Real-time PCR analysis. Real-time PCR amplification and
detection were performed on a LightCycler 2.0 instrument
(Roche) in 20-ml volumes containing 2 ml of cDNA reactions or
5 ml of DNA eluates, PCR reagents, target-specific primers, and
(for HSV-1 transcripts and EGFP) dual-labeled fluorescent
probes (Biomers, Ulm, Germany). Chicken b-actin PCR was
carried out using the primers at 0.2 mM as reported by Philbin et
al. [99], and the LightCycler FastStart DNA Master
Plus SYBR
Green I Kit (Roche) according to the manufacturer’s instructions.
The specificity of the amplified products was assessed by
performing melting-curve analyses. DNA sequences and tran-
scripts of the HSV-1 genes ICP27/UL54 and UL44/gC, and the
2.0-kb intron of LAT were quantified using the primers at
0.4 mM and the dual-labeled probes at 0.2 mM, as described by
Cohrs et al. [100]. UL27/gB sequences were amplified using the
primers at 0.5 mM and the dual-labeled probe at 0.2 mM, as
reported by Mador et al. [101]. A 75-bp region of the EGFP
transgene was amplified using the primers at 0.5 mM and the
dual-labeled probe at 0.1 mM, as described previously by Pan et
al. [102]. Probes were labeled with the fluorescent dye 6-
carboxyfluorescein at the 59 end and with the quencher dye 6-
carboxytetramethylrhodamine at the 39 end. PCRs using
hydrolysis probes were set up with the LightCycler TaqMan
Master Kit (Roche) following the manufacturer’s protocol. All
PCR runs comprised a hot-start preincubation cycle and 45
quantification cycles.
Variations in the efficiency of nucleic acid extraction were taken
into account by coamplification of the housekeeping gene b-actin, as
reported by Bode et al. [103]. Samples containing conspicuously low
levels of b-actin genomic DNA and/or cDNA levels (e.g., more than
3 crossing point (Cp) values difference compared to average samples)
were treated as outliers and excluded from further experiments. For
the determination of relative levels of viral transcripts, Cp values of




, according to Bode et al. [103].
Standard curves for the quantification of HSV-1 genes and EGFP
were generated from tenfold serial dilutions of purified gDNA of
H S V - 11 7s y n
+ and pEGFP-1 vector, respectively.
Data were analyzed statistically using InStat software (version
3.0b, Graph Pad, La Jolla, CA, USA). HSV-1 DNA-negative
samples were excluded from statistical analyses of HSV-1 genome
and transcript levels. The significance of differences in genome
levels was determined by comparing the number of genomes per
TGE. The significance of differences between relative levels of
viral transcripts was calculated by comparing differences in Cp
values (Cp b-actin2Cp transcript). Cp values of 40.01 and 41 were
applied to samples containing transcript levels below the linear
range of qPCR (Cp.40) or with no detectable levels of viral
transcripts, respectively.
In order to determine the detection limit of RT-PCR assays
performed on samples from infected cells, Vero cells were infected
with HSV-1 17 CMV-IEproEGFP at an MOI of 1 and serial
tenfold dilutions for 1 h at 37uC. At 3 hpi,cells were trypsinized and
washed with PBS. Genomic DNA and RNA were extracted from
5610
5 cells using the Allprep DNA/RNA Mini Kit (Qiagen), and
cDNA was synthesized as described above. Both ICP27 and EGFP
were amplified by qPCR using triplicate samples of gDNA and
cDNA, respectively. The lower limit of the linear range of
quantification was found to lie between 50 and 100 copies of
gDNA per 20 ml of PCR reaction mixture, while transcripts could
still be measured in samples from cells infected at an MOI of 10
25.
HSV-2 genomes in infected TGEs were quantitated using the
Light Cycler HSV-1/2 Qual Kit (Roche) and internal quantitative
standards consisting of serially tenfold diluted, purified HSV-2 333
DNA.
Immunofluorescence
TGEs were fixed at different times post infection for 3 h in 4%
phosphate-buffered paraformaldehyde (pH 7.4) at 4uC. Fixed
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woude, The Netherlands) and frozen in isopentane cooled in
liquid nitrogen. Cryosections were cut at a thickness of 7 mmo n
a cryotome (CM3050, Leica, Bensheim, Germany) and mounted
on coated slides (Superfrost Plus, Langenbrinck, Emmendingen,
Germany). Fluorescence immunohistochemistry was performed
on frozen sections using previously described standard protocols
[104]. The polyclonal anti-HSV-1 antibody (Dako, Glostrup,
Denmark) was diluted to 1:200 and incubated with the sections
overnight at 4uC. A biotinylated a-rabbit secondary antibody
(Vector Laboratories, Burlingame, CA, USA) was used, followed
by fluorescence-signal detection with A488-streptavidin (Molec-
ular Probes, Leiden, Netherlands). Nuclei were stained using a
mounting medium containing DAPI (Vector Laboratories).
Sections were examined with a fluorescence microscope (DM,
Leica), and images were digitized and transferred to a computer
using a Diagnostic Instruments SPOT II camera system
(Visitron, Munich, Germany). The monochrome fluorescence
signals were merged into a single multicolor image using SPOT
II software.
Preparations of dispersed TGEs were obtained, processed for
immunofluorescence and stained with HSV-1-specific rabbit
antiserum, a monoclonal antibody against the 200 kD neurofil-
ament marker (Roche) and DAPI as described by Hafezi et al.
[43].
Fluorescence imaging of intact TGEs
Daily monitoring of EGFP expression was performed with a
fluorescence microscope (Axiovert 200, Zeiss, Jena, Germany)
using a bandpass filter for EGFP (AHF Analysentechnik,
Tu ¨bingen, Germany). Images were obtained using an AxioCam
MRm camera (Zeiss) and AxioVision 4.6 software (Zeiss).
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